We saw some strong moves in biotech and healthcare stocks today. One of the biggest movers was Bristol-Myers Squibb Company (BMY). The stock was up over 3% with over an hour left in the session. Most of the movement can be attributed to two upgraded price targets on the stock from Credit Suisse and BMO Capital, with a target of $61 for the former and $57 for the latter. BMY traded to as high at $58.88 as of 2:40PM EST. Here’s a recap of what happened.